Paxlovid rebound happens, though why and to whom are still a mystery
Covid has settled into a persistent pattern — and remains damaging. It may not change anytime soon
Patients seeking novel weight loss drugs find a ‘wild west’ of online prescribers
The trust-builder: a cancer center director’s try-it-all strategy for breaking the barriers between research and Black patients
Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
The need for speed and safety: A primer on the FDA’s drug approval pathways
Continuous glucose monitoring: how it’s advancing diabetes care
The ‘shroom boom’: The meteoric rise of the psychedelic medicine industry
